Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JCR Pharmaceuticals
Asia
Biogen-Eisai, Samsung-Roche, Sunovion-Otsuka—Fierce Pharma Asia
Biogen and Eisai seek fast approval for Alzheimer's med. Samsung Biologics and Roche expand their partnership. Otsuka licenses four Sunovion meds.
Angus Liu
Oct 1, 2021 10:00am
Takeda, JCR ink deal to commercialize Hunter syndrome drug
Sep 30, 2021 10:35am
Japan will buy 120 million shots from AZ starting early in 2021
Aug 7, 2020 9:30am